SKYE
Skye Bioscience Inc

4,616
Mkt Cap
$37.35M
Volume
241,910.00
52W High
$5.75
52W Low
$1.14
PE Ratio
-1.01
SKYE Fundamentals
Price
$1.30
Prev Close
$1.17
Open
$1.18
50D MA
$2.19
Beta
1.02
Avg. Volume
1.69M
EPS (Annual)
-$0.7281
P/B
1.23
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
Skye Bioscience, Inc. Class Action: The Gross Law Firm Reminds Skye Bioscience, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 16, 2026 - SKYE
Skye Bioscience, Inc. Class Action: The Gross Law Firm Reminds Skye Bioscience, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 16, 2026 - SKYE Skye...
PR Newswire·15h ago
News Placeholder
More News
News Placeholder
UPCOMING DEADLINE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Skye Bioscience
UPCOMING DEADLINE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Skye Bioscience UPCOMING DEADLINE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Skye...
PR Newswire·4d ago
News Placeholder
SKYE INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Skye Bioscience, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
SKYE INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Skye Bioscience, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit SKYE INVESTOR ALERT...
PR Newswire·4d ago
News Placeholder
SKYE Investors Have Opportunity to Lead Skye Bioscience, Inc. Securities Fraud Lawsuit
SKYE Investors Have Opportunity to Lead Skye Bioscience, Inc. Securities Fraud Lawsuit SKYE Investors Have Opportunity to Lead Skye Bioscience, Inc. Securities Fraud Lawsuit PR Newswire NEW YORK...
PR Newswire·5d ago
News Placeholder
SKYE Investors Have Opportunity to Lead Skye Bioscience, Inc. Securities Fraud Lawsuit With the Schall Law Firm
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Skye Bioscience, Inc. (Skye or the Company) (NASDAQ: SKYE) for violations of...
Business Wire·6d ago
News Placeholder
Rosen Law Firm Urges Skye Bioscience, Inc. (NASDAQ: SKYE) Stockholders with Large Losses to Contact the Firm for Information About Their Rights
Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers and acquirers of Skye Bioscience, Inc. (NASDAQ: SKYE) securities between November 4, 2024...
Business Wire·6d ago
News Placeholder
Insights Ahead: Skye Bioscience's Quarterly Earnings
read more...
Benzinga·17d ago
News Placeholder
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Skye Bioscience, Inc. - SKYE
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Skye Bioscience, Inc. - SKYE INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Skye...
PR Newswire·28d ago
News Placeholder
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Skye Bioscience, Inc. - SKYE
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Skye Bioscience, Inc. - SKYE INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Skye...
PR Newswire·1mo ago
News Placeholder
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Skye Bioscience, Inc. - SKYE
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Skye Bioscience, Inc. - SKYE INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Skye...
PR Newswire·2mo ago

Latest SKYE News

View

Advertisement|Remove ads.

Advertisement|Remove ads.